Results 201 to 210 of about 20,458 (226)
Some of the next articles are maybe not open access.
Mutational analysis of TSC1 and TSC2 genes in gangliogliomas
Neuropathology and Applied Neurobiology, 2001Gangliogliomas constitute the most frequent tumour entity in patients with temporal lobe epilepsy. The characteristic histopathological admixture of glial and neuronal elements, the focal nature and their differentiated phenotype and benign biological behaviour suggest an origin from a developmentally compromised or dysplastic precursor lesion.
Becker, A.J. +10 more
openaire +3 more sources
Prognostic implication of TSC1 and mTOR expression in gastric carcinoma
Journal of Surgical Oncology, 2014BackgroundGastric adenocarcinoma is the sixth most common and third most lethal cancer in the world. Except for HER2‐targeted therapy, targeted agents against specific molecules participating in gastric carcinogenesis, including those in the mechanistic target of rapamycin (serine/threonine kinase) (mTOR) pathway have not been proved to be effective ...
Sun-Ju, Byeon +4 more
openaire +2 more sources
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Science, 1997Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the widespread development of distinctive tumors termed hamartomas. TSC-determining loci have been mapped to chromosomes 9q34 ( TSC1 ) and 16p13 ( TSC2 ).
van Slegtenhorst, Marjon +40 more
openaire +3 more sources
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 1999
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by seizures, mental retardation, and hamartomatous tumors in multiple organs, including subependymal giant cell astrocytomas, cardiac rhabdomyomas, and renal angiomyolipomas.
T L, Plank +3 more
openaire +1 more source
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by seizures, mental retardation, and hamartomatous tumors in multiple organs, including subependymal giant cell astrocytomas, cardiac rhabdomyomas, and renal angiomyolipomas.
T L, Plank +3 more
openaire +1 more source
Science Signaling, 2015
TSC1 functions independently of TSC2 and mTORC1 to promote TGF-β signaling.
openaire +1 more source
TSC1 functions independently of TSC2 and mTORC1 to promote TGF-β signaling.
openaire +1 more source
Journal of the American Society of Nephrology, 2023
Morgan E. Mackenzie +4 more
openaire +1 more source
Morgan E. Mackenzie +4 more
openaire +1 more source
The Circadian Protein Period2 Suppresses mTORC1 Activity via Recruiting Tsc1 to mTORC1 Complex
Cell Metabolism, 2019Fabin Dang, Zhengshuai Liu, Yu Li
exaly
TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway
Cellular and Molecular Immunology, 2015Linnan Zhu +2 more
exaly

